Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 7 to 11, 2020. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 7 to 11, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
BNT162b2 Vaccine 95 Percent Effective for Preventing COVID-19
FRIDAY, Dec. 11, 2020 (HealthDay News) — A two-dose regimen of a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a severe acute respiratory syndrome coronavirus 2 full-length spike protein, BNT162b2, is 95 percent effective for preventing COVID-19, according to a study published online Dec. 10 in the New England Journal of Medicine.
U.S. Marshals to Protect COVID-19 Vaccines
FRIDAY, Dec. 11, 2020 (HealthDay News) — COVID-19 vaccines will be protected by U.S. Marshals deputies as they are distributed throughout the United States.
ED Visits Related to Child Abuse, Neglect Dropped During COVID-19
FRIDAY, Dec. 11, 2020 (HealthDay News) — During the COVID-19 pandemic, there was a decrease in the total number of emergency department visits related to child abuse and neglect, according to research published in the Dec. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Hyposmia, Dysgeusia Common for Patients With COVID-19
FRIDAY, Dec. 11, 2020 (HealthDay News) — Loss of smell and taste are common in patients with COVID-19 infection, and these symptoms may precede systemic symptoms, according to a study published online Dec. 9 in Neurology Clinical Practice.
70 Percent Efficacy Found for Oxford COVID-19 Vaccine
FRIDAY, Dec. 11, 2020 (HealthDay News) — The ChAdOx1 nCoV-19 vaccine has an overall efficacy of 70.4 percent, with an acceptable safety profile, according to the results of an interim analysis published online Dec. 8 in The Lancet.
Essential Workers Have Increased Risk for Severe COVID-19
FRIDAY, Dec. 11, 2020 (HealthDay News) — Essential workers have an increased risk for severe COVID-19, according to a study published online Dec. 8 in Occupational & Environmental Medicine.
FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine
THURSDAY, Dec. 10, 2020 (HealthDay News) — The U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee today voted to recommend emergency use authorization of the COVID-19 vaccine manufactured by Pfizer and BioNTech.
American Indians/Alaska Natives Have Elevated COVID-19 Mortality
THURSDAY, Dec. 10, 2020 (HealthDay News) — American Indians/Alaska Natives have disproportionate COVID-19 mortality rates, according to research published in the Dec. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
FDA Authorizes First OTC COVID-19 Home Test Collection Kit
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
.jpg)